The clinical analysis of the efficacy and the timing of allogeneic hematopoietic stem cell transplantation(allo-HSCT)for high-risk myelodysplastic syndrome(MDS)and MDS-evolved leukemia(MDS-AML)

SONG Xiao-lu; WANG Xiao-gang; PENG Ye; JIN Lai; CHEN Yi-rui; LAN Jian-ping

doi:10.19538/j.nk2021100110

Home>Articles>The clinical analysis of the efficacy and the timing of allogeneic hematopoietic stem cell transplantation(allo-HSCT)for high-risk myelodysplastic syndrome(MDS)and MDS-evolved leukemia(MDS-AML)

DOI: 10.19538/j.nk2021100110

The clinical analysis of the efficacy and the timing of allogeneic hematopoietic stem cell transplantation(allo-HSCT)for high-risk myelodysplastic syndrome(MDS)and MDS-evolved leukemia(MDS-AML)

SONG Xiao-lu

WANG Xiao-gang

PENG Ye

JIN Lai

CHEN Yi-rui

LAN Jian-ping

Machine-generated Keywords：

Publication Date：2021-10-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：6( 867-872 )

Chinese Journal of Practical Internal Medicine

ISTICPKU

ISSN：1005-2194

Year, Vol.(Issue)：2021,41(10)